BRIEF-Glenmark Pharma expects to launch 20 generic products annually in U.S.

* Says Glenmark expects to file 2025 ANDAs and launch 20

generic products annually in the U.S.

Source text: http://bit.ly/2hLg0qA

Further company coverage:

Read more